Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
Photodynamic treatment of cancer is based on administering an initially inactive substance that is only activated in the ...
Plastic, once ingenious for its durability and versatility, has become a global environmental issue that is affecting every ...
As droughts worsen and freshwater grows scarce, desalination is expanding rapidly. More than 20,000 plants now convert ...
Japanese researchers developed a molybdenum-based spin-flip emitter that efficiently harvests triplet excitons from ...